Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	View
JXSL2200162	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-09-09	view
JXSL2200159	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-09-09	view
JXSL2200158	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-09-09	view
JXSL2200161	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-09-09	view
JXSL2200160	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-09-09	view
JXSL2200157	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-09-09	view
JXSS2101008	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2021-06-25	view
JXSS2101010	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2021-06-25	view
JXSS2101009	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2021-06-25	view
JXSS2101012	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2021-06-25	view
JXSS2101011	注射用培重组人凝血因子Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2021-06-25	view